| Title |
ROW |
| 4S-DT : Self Supervised Super Sample Decomposition for Transfer learning with application to COVID-19 detection |
4101 |
| A geospatial infodemic: Mapping Twitter conspiracy theories of COVID-19 |
4102 |
| A graph-based approach identifies dynamic H-bond communication networks in spike protein S of SARS-CoV-2 |
4103 |
| A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti- infective drugs for COVID-19 |
4104 |
| A summary of the diagnostic and prognostic value of hemocytometry markers in COVID-19 patients |
4105 |
| Acute abducens nerve palsy in a patient with the novel coronavirus disease (COVID-19) |
4106 |
| An interpretable mortality prediction model for COVID-19 patients – alternative approach |
4107 |
| Antinuclear Antibodies and Lupus-like Manifestations in Rheumatoid Arthritis and Ankylosing Spondylitis patients at 4 Months' Follow-up After Treatment with Infliximab and Etanercept |
4108 |
| Are men who smoke at higher risk for a more severe case of COVID-19 than women who smoke? A Systematic Review |
4109 |
| Artificial Intelligence-Based Clinical Decision Support for COVID-19–Where Art Thou? |
4110 |
| Asthma in children during the COVID-19 pandemic: lessons from lockdown and future directions for management |
4111 |
| Bereavement, grief, and consolation: Emotional-affective geographies of loss during COVID-19 |
4112 |
| Buying time: Drug repurposing to treat the host in COVID-19H |
4113 |
Can tocilizumab calm the cytokine storm of COVID-19?
|
4114 |
| Care of newborns born to mothers with COVID-19 infection; a review of existing evidence |
4115 |
| CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2 and are differentially expressed in lung and kidney epithelial and endothelial cells |
4116 |
| Characteristics and Therapeutic Options of the Coronavirus Disease 2019 |
4117 |
| Children with COVID-19 at a specialist centre: initial experience and outcome |
4118 |
| Choosing Anticonvulsant Medications to Manage Status Epilepticus |
4119 |
| Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium |
4120 |
| Common trends in the epidemic of Covid-19 disease |
4121 |
| Comorbidities might be a risk factor for the incidence of COVID-19: Evidence from a web-based survey of 780,961 participants |
4122 |
| Conceptual Design of a Body Bag for Preventing Infections and Safe Disposal of Deceased from COVID‑19 Virus |
4123 |
| Consideration on TMPRSS2 and the risk of COVID-19 infection in Cushing’s syndrome |
4124 |
| CORDITE: the curated CORona Drug InTERactions database for SARS-CoV-2 |
4125 |
| Cost-effectiveness and return on investment of protecting health workers in low- and middle-income countries during the COVID-19 pandemic |
4126 |
| Could Anti-Tubercular Vaccination Protect Against Covid-19 Infection? |
4127 |
Covid-19 and the Need for Health Care Reform
|
4128 |
| COVID-19 heralds a new era for chronic diseases in primary care |
4129 |
| COVID-19 in an international European liver transplant recipient cohort |
4130 |
COVID-19 in Iran: round 2
|
4131 |
| COVID-19 infection in solid organ transplant recipients: a single center experience with patients immediately after transplantation |
4132 |
| COVID-19 Outbreak Impact on Neonatal Emergency Transport |
4133 |
| COVID-19 Outpatient Screening: a Prediction Score for Adverse Events |
4134 |
| COVID-19 severity is associated with immunopathology and multi-organ damage |
4135 |
| Covid-19, Place-making and Health |
4136 |
| Antiviral effects of Nano Colloidal Silver,Water Catholyte, Oxidal with Methylene Blue. Possible Effects of Influence over Coronavirus SARS-CoV and SARS-CoV-2 with Disease COVID-19 |
4137 |
| Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding |
4138 |
| Detailed phylogenetic analysis of SARS-CoV-2 reveals latent capacity to bind human ACE2 receptor |
4139 |
| Determinants of COVID-19 disease severity in patients with cancer |
4140 |
| Development of the platform “Be+ against COVID”, a website and a mobile app to prevent and address the stress reactions of healthcare workers caring COVID-19 patients. |
4141 |
| Diabetes increases the mortality of patients with COVID‑19: a meta‑analysis |
4142 |
| Discovery of Fungal Metabolites Bergenin, Quercitrin and Dihydroartemisinin as Potential Inhibitors Against Main Protease of SARS-CoV-2 |
4143 |
| DReAM-in-cDM Approach and Identification of a New Generation of Anti-inflammatory Drugs Targeting mPGES-1 |
4144 |
| Efficacy and safety of chloroquine or hydroxychloroquine in moderate type of COVID-19: a prospective open-label randomized controlled study |
4145 |
| Efficacy of contact tracing for the containment of the 2019 novel coronavirus (COVID-19) |
4146 |
| Epidemiological and clinical characteristics in patients with SARS-CoV-2 antibody negative probable COVID-19 in Wuhan |
4147 |
| Evaluation of Conjunctival Swab PCR Results in Patients with SARS-CoV-2 Infection |
4148 |
| Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti- inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators |
4149 |
| Far-UVC light (222nm) efficiently and safely inactivates airborne human coronaviruses |
4150 |
| Focus on Characteristics of COVID-19 with the Special Reference to the Impact of COVID-19 on the Urogenital System |
4151 |
| Fuzzy logic assisted COVID 19 safety assessment of dental care |
4152 |
Generation coronavirus?
|
4153 |
| GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches |
4154 |
| HIV protease inhibitors saquinavir and nelfinavir are potent inhibitors of cathepsin L activity- A potential treatment for COVID-19 patients |
4155 |
| How Have COVID-19 Isolation Policies Affected Young People’s Mental Health? – Evidence From Chinese College Students |
4156 |
| Hypercytokinemia and Pathogen–Host Interaction in COVID-19 |
4157 |
| Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients |
4158 |
| In-hospital Use of Statins is Associated with a Reduced Risk of Mortality among Individuals with COVID- 19 |
4159 |
| Inpatient Dermatology Consultations during Covid 19 Pandemic in a Tertiary Referral Center |
4160 |
| Intrafamilial Exposure to SARS-CoV-2 Induces Cellular Immune Response without Seroconversion |
4161 |
| Is Alcohol More Dangerous Than Severe Acute Respiratory Syndrome Coronavirus 2 in Iran? |
4162 |
| Is the use of ACE inb/ARBs associated with higher in-hospital mortality in Covid-19 pneumonia patients? |
4163 |
| Knowledge, attitudes, risk perceptions, and practices of adults toward COVID-19: a population and field-based study from Iran |
4164 |
| Laboratory characteristics of pregnant compared to non‑pregnant women infected with SARS‑CoV‑2 |
4165 |
| Low-grade fever during COVID-19 convalescence- A report of 3 cases |
4166 |
| Management of Infantile Spasms During the COVID-19 Pandemic |
4167 |
| Management of patients with liver derangement during theCOVID-19 pandemic: an Asia-Pacific position statement |
4168 |
| Management strategies for the colonoscopic surveillance of people with Lynch syndrome during the COVID-19 pandemic |
4169 |
| Mapping COVID-19: How web-based maps contribute to the infodemic |
4170 |
| Medicine lines and COVID-19: Indigenous geographies of imagined bordering |
4171 |
| Mounting clues suggest the coronavirusmight triggerdiabetes |
4172 |
| Myocarditis in a 16-year-old boy positive for SARS-CoV-2 |
4173 |
| Nature and nowness under lockdown |
4174 |
| Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study |
4175 |
| Ocular Manifestations of Hospitalized Patients with COVID-19 in Northeast of Iran |
4176 |
| Offline: The second wave |
4177 |
| Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis. |
4178 |
| Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomized controlled trial in European primary care from 2016 to 2018 |
4179 |
| Pandemic publishing poses a new COVID-19 challenge |
4180 |
| Platelets can contain SARS-CoV-2 RNA and are hyperactivated in COVID-19 |
4181 |
| Polymorphisms in the ACE2 Locus Associate with Severity of COVID-19 Infection |
4182 |
| Potential contribution of increased soluble IL-2R to lymphopenia in COVID-19 patients |
4183 |
| Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography |
4184 |
| Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies |
4185 |
| temporal radiographic changes in COVID-19 patients: relationship to disease severity and viral clearance |
4186 |
| The covid-19 Crisis: A Challenge for Numeric Comparative Law and Governance |
4187 |
| The COVID-19 Serology Studies Workshop: Recommendations and Challenges |
4188 |
| Reproducing the long term predictions from Imperial College CovidSim Report 9 |
4189 |
| The R0 journey- from 1950s malaria to COVID-19 |
4190 |
| The Relationship between Ambient Temperature and Positive Cases of COVID-19; A Case Study in Abarkouh and Qeshm Cities of Iran |
4191 |
| Thrombotic microvascular injury is not mediated by thrombotic microangiopathy despite systemic complement activation in Covid-19 patients |
4192 |
| Tocilizumab in patients with severe COVID-19: a retrospective cohort study |
4193 |
| Transcriptomic profiling of disease severity in patients with COVID-19 reveals role of blood clotting and vasculature related genes |
4194 |
| Treatment Intensity Stratification in COVID-19 by Fully Automated Analysis of Pulmonary and Cardiovascular Metrics on Initial Chest CT using Deep Learning |
4195 |
| Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD |
4196 |
| Use of aerosolised medications at home for COVID-19 |
4197 |
| What association do political interventions, environmental and health variables have with the number of Covid-19 cases and deaths? A linear modeling approach |
4198 |
| 2020-JCR-Editorial-Expression-of-Concern-FINAL-SENT-1-2 |
4199 |
A facile Q-RT-PCR assay for monitoring SARS-CoV-2 growth in cell culture
|
4200 |
| A novel covid-19 mathematical model with fractional derivatives: singular and nonsingular kernels |
4201 |
| A Precursor on Pandemic Corona Virus: An Infectious Disease |
4202 |
| A SIR model assumption for the spread of COVID-19 in different communities |
4203 |
| A Streamlined CyTOF Workflow To Facilitate Standardized Multi-Site Immune Profiling of COVID-19 Patients |
4204 |
| A universal design of betacoronavirus vaccines against COVID-19, MERS and SARS |
4205 |
| Age Associated Coronavirus Disease 2019 Incubation Period: Impact on Quarantine Policy |
4206 |
| Axiology of COVID-19 as a Linguistic Phenomenon in English Mass Media Discourse |
4207 |
| Can Masks Be Reused After Hot Water Decontamination During the COV‐ ID-19 Pandemic? |
4208 |
| Cancer and COVID-19: Currently in Race for the Title of “The Emperor of All Maladies!” |
4209 |
| Cancer survivorship care at the time of the COVID-19 pandemic |
4210 |
| CAR T-Cell Treatment During the COVID-19, Pandemic: Management Strategies and Challenges |
4211 |
| Chest CT in asymptomatic COVID-19: benefits and concerns |
4212 |
| Children’s emergency presentations during the COVID-19 pandemic |
4213 |
| Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis |
4214 |
| Clinical Trials Facing “Serious Adverse Events” during the Ongoing COVID-19 Pandemic |
4215 |
| Clinical utility of chest radiography for severe COVID-19 |
4216 |
| Could there be a link between oral hygiene and the severity of SARS-CoV-2 infections? |
4217 |
| COVID-10 in South Korea: lessons for developing countries |
4218 |
| COVID-19: A series of important recent clinical and laboratory reports in immunology and pathogenesis of SARS-CoV-2 infection and care of allergy patients |
4219 |
| COVID-19 and International Food Assistance: Policy Proposals to Keep Food Flowing |
4220 |
| COVID-19 and nonalcoholic fatty liver disease: two intersecting pandemics |
4221 |
| Covid-19 health crisis and lockdown associated with high level of sleep complaints and hypnotic uptake at the population level |
4222 |
| COVID-19 in Spain sewage brings origin of virus a step closer |
4223 |
| COVID-19 Infection Cause Moderate-Severe Psoriasis Flare Up |
4224 |
| COVID-19: Targeting the cytokine storm via cholinergic anti- inflammatory (Pyridostigmine) |
4225 |
| Covid-19: The Regulatory Landscape of Medicinal and Medical Device Products for Human Use |
4226 |
| Critical Sequence Hot-spots for Binding of nCOV-2019 to ACE2 as Evaluated by Molecular Simulations |
4227 |
| Current landscape of Imaging and the potential role for Artificial intelligence in the management of COVID-19 |
4228 |
| Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic review of the literature. |
4229 |
| Cytokine Storms: Understanding COVID-19 |
4230 |
| Dexamethasone |
4231 |
| DISTANCING BONUS OR DOWNSCALING LOSS? THE CHANGING LIVELIHOOD OF US ONLINE WORKERS IN TIMES OF COVID-19 |
4232 |
| Do Quarantine Experiences and Attitudes Towards COVID-19 Affect the Distribution of Mental Health in China? A Quantile Regression Analysis |
4233 |
| Double lock the COVID-19: inhibit SARS-COV-2 replication and suppress inflammation cytokine level by the golden compounds |
4234 |
| Employee presenteeism and occupational acquisition of COVID-19 |
4235 |
| Ensuring Uptake of Vaccines against SARS-CoV-2 |
4236 |
| First comes the A, then comes the B: what we have learned from the COVID-19 outbreak. |
4237 |
| Forecasting spatial, socioeconomic and demographic variation in COVID-19 health care demand in England and Wales |
4238 |
| Great Power Blame Game: The OngoingWar of Words Over COVID-19 |
4239 |
| Grief and the COVID-19 Pandemic in Older Adults |
4240 |
| Helping Couples in the Shadow of COVID-19 |
4241 |
| Hesperidin and SARS-CoV-2: New Light on the Healthy Functions of Citrus Fruit |
4242 |
| How the COVID-19 pandemic may impact public support for clinical xenotransplantation in the United States? |
4243 |
| Identification of pathophysiological patterns for triage and respiratory support in COVID-19 |
4244 |
| Identification of SARS-CoV-2 RNA in Healthcare Heating, Ventilation, and Air Conditioning Units |
4245 |
| Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A Systematic Review |
4246 |
| Integrate Structural Analysis, Isoform Diversity, and Interferon- Inductive Propensity of ACE2 to Refine SARS-CoV2 Susceptibility Prediction in Vertebrates |
4247 |
| International Survey of Trials of Convalescent Plasma to Treat COVID-19 Infection |
4248 |
| Errors in search strategies used in systematic reviews and their effects on information retrieval |
4249 |
| Literature Review of Epidemiological Phenomena: Corona Virus Disease Pandemic 2019 |
4250 |
Manifestations of blood coagulation and its relation to clinical outcomes in severe COVID-19 patients: Retrospective analysis
outcomes in severe COVID-19 patients: Retrospective analysis |
4251 |
| Modified Vaccinia Ankara Based SARS-CoV-2 Vaccine Expressing Full-Length Spike Induces Strong Neutralizing Antibody Response |
4252 |
| New coronavirus disease (COVID-19): Clinical symptoms other than pneumonia with emphasis on thrombosis |
4253 |
| Pathophysiology of the COVID-19 – entry to the CNS through the nose |
4254 |
| Percutaneous dilatational tracheostomy for saturating influx of COVID-19 patients: experience of military ENT physicians deployed in Mulhouse, France |
4255 |
| Predicting adaptive and maladaptive responses to the Coronavirus (COVID-19) outbreak: A prospective longitudinal study |
4256 |
| Preliminary Clinical and Epidemiological Analysis of the First 1,000 Pediatric COVID-19 Cases inMoscow Region |
4257 |
| Psychological states of COVID-19 quarantine |
4258 |
| Reaching Up, Down, In, and Around: Couple and Family Coping During the Corona Virus Pandemic |
4259 |
| Repurposing Prolactin as a Promising Immunomodulator for the Treatment of COVID-19: Are Common Antiemetics the Wonder Drug to Fight Coronavirus? |
4260 |
| Ruxolitinib for tocilizumab-refractory severe COVID-19 infection |
4261 |
| SARS-CoV-2 impact on the Central Nervous System: Are astrocytes and microglia main players or merely bystanders? |
4262 |
| Secondary pneumonia in critically ill ventilated patients with COVID-19 |
4263 |
| Semen quality as a potential susceptibility indicator to SARS-CoV-2 insults in polluted areas |
4264 |
| Serum calcium as a biomarker of clinical severity and prognosis in patients with coronavirus disease 2019: a retrospective cross-sectional study |
4265 |
| Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population |
4266 |
| Short Communication: Vitamin D and COVID-19 infection and mortality in UK Biobank |
4267 |
| Structures, conformations and distributions of SARS-CoV-2 spike protein trimers on intact virions |
4268 |
| Tele-consultations in the wake of COVID-19 – Suggested guidelines for clinical ophthalmology |
4269 |
| The Benefits of Coronavirus Suppression A Cost-Benefit Analysis of the Response to the First Wave of COVID-19 |
4270 |
| The Global Phosphorylation Landscape of SARS-CoV-2 Infection |
4271 |
| The impact of SARS-CoV-2 transmission fear and COVID-19 pandemic on the mental health of patients with primary immunodeficiency disorders, severe asthma, and other high-risk groups |
4272 |
| The Impact of the COVID-19 Pandemic on Unhealthy Eating in Populations with Obesity |
4273 |
| The Predicted Structure For The Anti Sense Sirna Of The Rna Polymerase Enzyme Rdrp Gene Of The Sars Cov 2 |
4274 |
| The Reopening of Schools and Adoption of UniversalWearing of Face Masks in Anticipation of Sustained transmission or the SecondWave of COVID-19 with the Influenza Virus |
4275 |
| Title Suppressions |
4276 |
| Transcriptomic signatures and immunomodulatory treatments for COVID-19 patients |
4277 |
| Trends in clinical features of novel coronavirus disease (COVID-19): A systematic review and meta-analysis of studies published from December 2019 to February 2020 |
4278 |
| Vaporized H2O2 decontamination against surrogate viruses for the reuse of N95 respirators in the COVID‐19 emergency |
4279 |
| Voices from a Pandemic |
4280 |
| When two pandemics meet: Why is obesity associated with increased COVID-19 mortality? |
4281 |
| Hypothesis why vertical SARS-CoV-2 infection can occur and is rare A text / data mining study guided by biochemical knowledge. |
4282 |
| Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19 |
4283 |
| Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications on its protein structure |
4284 |
| Identification of peptide candidate against COVID-19 through reverse vaccinology: An immunoinformatics approach |
4285 |
| If the link missed：Could inflammatory skin disorders with barrier dysfunction increase the risk of COVID-19? |
4286 |
| Immunity to COVID-19 is probably higher than tests have shown |
4287 |
| Impact of COVID-19 event on the air quality in Iran |
4288 |
| Impact of COVID-19 on liver transplantation in Europe: Alert from an early survey of European Liver and Intestine Transplantation Association (ELITA) and European Liver Transplant Registry (ELTR) |
4289 |
| In silico analysis and identification of promising hits against 2019 novel coronavirus 3C-like main protease enzyme |
4290 |
| In silico exploration of small-molecule α-helix mimetics as inhibitors of SARS-COV-2 attachment to ACE2. |
4291 |
| NCIDENCE OF ARRHYTHMIAS AND ELECTROCARDIOGRAPHIC ABNORMALITIES IN SYMPTOMATIC PEDIATRIC PATIENTS WITH PCR POSITIVE SARS-CoV-2 INFECTION INCLUDING DRUG INDUCED CHANGES IN THE CORRECTED QT INTERVAL (QTc). |
4292 |
| Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights |
4293 |
| Indirect effects of COVID‑19 on child health care: delayed diagnosis of developmental dysplasia of the hip |
4294 |
| Inequities in access to education: Lessons from the COVID-19 pandemic |
4295 |
| Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections |
4296 |
| Investigating the Effects of COVID-19 Quarantine on Migraine: Data from the Italian National Headache Registry (RICe) |
4297 |
| Is BMI higher in younger patients with COVID-19? Association between BMI and COVID-19 hospitalization by age |
4298 |
| Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic |
4299 |
| Kawasaki disease in the COVID-19 era: a distinct clinical phenotype? |
4300 |
| Long-distance airborne dispersal of SARS-CoV-2 in COVID-19 wards |
4301 |
| Long-Term Hemodialysis during the COVID-19 Pandemic |
4302 |
| Low Humoral Immune Response and Ineffective Clearance of SARS-Cov-2 in a COVID-19 Patient With CLL During a 69-Day Follow-Up |
4303 |
| Making sense of mutation: what D614G means for the COVID-19 pandemic remains unclear |
4304 |
| Male gender and kidney illness associated with an increased risk of severe laboratory- confirmed coronavirus disease |
4305 |
| Management strategies for children with COVID-19: ESPR practical recommendations |
4306 |
| Mapping the T cell response to COVID-19 |
4307 |
| Massage Therapy for Pulmonary Function in Patients Recovering From Covid-19: A Protocol for Systematic Review and Meta-analysis |
4308 |
| Massive transient damage of the olfactory epithelium associated with infec tion of sustentacular cells by SARS-CoV-2 in golden Syrian hamsters |
4309 |
| Medical Concepts with Clinical-Epidemiological Implications that have to be Re-Assessed Since the Coronavirus Disease 2019 (Covid-19) Pandemic |
4310 |
| Medical Students’ Commitment during the SARS-CoV-2 Pandemic: Preparedness, Motivation, and impact on Students’ Skills |
4311 |
| Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment |
4312 |
| Mesenchymal stromal cells and their secreted extracellular vesicles as therapeutic tools for COVID-19 pneumonia? |
4313 |
| Microstructure, pathophysiology and potential therapeutics of COVID-19: A comprehensive review |
4314 |
| Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients |
4315 |
| Mitigate risks of medication interruption due to COVID-19 for elderly with chronic diseases |
4316 |
| MORT, a locus for apoptosis in the human immunodeficiency virus-type 1 antisense gene: implications for AIDS, Cancer, and Covid-19 |
4317 |
Moving beyond isolated events
|
4318 |
| Multicenter comparison of the Cobas 6800 system with the RealStar RT-PCR kit for the detection of SARS-CoV-2 |
4319 |
| Multisystem Inflammatory Syndrome in Children in COVID-19 Pandemic |
4320 |
| Multisystem Inflammatory Syndrome in Children in New York State |
4321 |
| Multisystem Inflammatory Syndrome in U.S. Children and Adolescents |
4322 |
| Must there be a “war” against coronavirus? |
4323 |
| Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series |
4324 |
| Natural History of COVID-19 and Current Knowledge on Treatment Therapeutic Options |
4325 |
| Neurobiology of COVID-19 |
4326 |
| Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children |
4327 |
| Neurologic manifestations of nonhospitalized patients with COVID-19 inWuhan, China |
4328 |
| Neurological Complications of COVID-19: A Systematic Review of Literature |
4329 |
| Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV- SARS-CoV-2 and a clinical isolate of SARS-CoV-2. |
4330 |
| New approaches to cancer care in a COVID-19 world |
4331 |
| Nicotine and smoking in the COVID-19 era |
4332 |
| Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2 |
4333 |
| Nosocomial SARS-CoV-2 Infections in Japan: A Cross- sectional Newspaper Database Survey |
4334 |
| Not just little adults: preparing a children’s emergency department for COVID-19 |
4335 |
| On order and disorder during the COVID-19 pandemic |
4336 |
| One U.K. trial is transforming COVID-19 treatment. Why haven’t others delivered more results? |
4337 |
| Oropharyngeal candidiasis in hospitalized COVID-19 Patients from Iran: Species identification and antifungal susceptibility pattern |
4338 |
| periscope: sub-genomic RNA identification in SARS-CoV-2 ARTIC Network Nanopore Sequencing Data |
4339 |
| Perspective: Vitamin D deficiency and COVID-19 severity – plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2, and thrombosis (R1) |
4340 |
| Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report |
4341 |
| Point of Care Ultrasound During the Covid-19 Pandemic Should Screen for Inter-Atrial Shunt |
4342 |
| Politicizing the Pandemic: A Schemata Analysis of COVID‑19 News in Two Selected Newspapers |
4343 |
| Positive effects of covid-19 and social determinants of health: all in it together? |
4344 |
| Possible Protective Effect of Renin-Angiotensin System Inhibitors in COVID-19 Induced Acute Kidney Injury |
4345 |
| Potential of regulatory T cell-based therapies in the management of severe COVID-19 |
4346 |
| Practical lessons learned for assessing and treating bipolar disorder via telehealth modalities during the COVID-19 pandemic |
4347 |
| Presymptomatic viral shedding and infective ability of Severe Acute Respiratory Syndrome coronavirus2 |
4348 |
| Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques |
4349 |
| Prophylactic (hydroxy)chloroquine in COVID-19: potential relevance for cardiac arrhythmia risk |
4350 |
| Hypothesis why vertical SARS-CoV-2 infection can occur and is rare A text / data mining study guided by biochemical knowledge. |
4351 |
| Protection Challenges of Pregnant Women against Vertical Transmission during COVID-19 Epidemic: A Narrative Review |
4352 |
| Protracted ketonaemia in hyperglycaemic emergencies in COVID-19: a retrospective case series |
4353 |
| Psychology and COVID-19: impacts, themes and way forward |
4354 |
| Public behavior change, perceptions, depression, and anxiety in relation to the COVID-19 outbreak |
4355 |
| Pulmonary intravascular coagulopathy in COVID-19 pneumonia |
4356 |
| Pulmonary intravascular coagulopathy in COVID-19 pneumonia |
4357 |
| Pulmonary intravascular coagulopathy in COVID-19 pneumonia |
4358 |
| Pulmonary intravascular coagulopathy in COVID-19 pneumonia |
4359 |
| Radiomics nomogram for the prediction of 2019 novel coronavirus pneumonia caused by SARS-CoV-2 |
4360 |
| Rapid and accurate detection of novel coronavirus SARS-CoV-2 using CRISPR-Cas3 |
4361 |
| Recent New Results and Achievements of California South University (CSU) BioSpectroscopy Core Research Laboratory for COVID-19 or 2019-nCoV Treatment: Diagnosis and Treatment Methodologies of“Coronavirus” |
4362 |
| Recognition of COVID-19 disease from X-ray images by hybrid model consisting of 2D curvelet transform, haotic salp swarm algorithm and deep learning technique |
4363 |
| The art of medicine Reflecting on experiences of social distancing |
4364 |
| Re-imagining Health Research Partnership in a Post-COVID World: A Response to Recent Commentaries |
4365 |
| Research in counselling and psychotherapy Post-COVID-19 |
4366 |
| Reshaping ophthalmology training after COVID-19 pandemic |
4367 |
| Review of Burden, Clinical Definitions, and Management of COVID-19 Cases |
4368 |
| Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19 |
4369 |
| Role of digital pathology in diagnostic histopathology in the response to COVID-19: results from a survey of experience in a UK tertiary referral hospital |
4370 |
| Routine measurement of serum procalcitonin allows antibiotics to be safely withheld in patients admitted to hospital with SARS-CoV-2 infection. |
4371 |
| Far-UVC light (222nm) efficiently and safely inactivates airborne human coronaviruses |
4372 |
| SARS-CoV2 coronavirus: So far polite with children. Debatable immunological and non-immunological evidence |
4373 |
| SARS-CoV-2 epitopes are recognized by a public and diverse repertoire of human T-cell receptors |
4374 |
| SARS-CoV-2 nucleocapsid assembly inhibitors: Repurposing antiviral and antimicrobial drugs targeting nucleocapsid-RNA interaction |
4375 |
| SARS-CoV-2 reactive T cells in uninfected individuals are likely expanded by beta-coronaviruses |
4376 |
| SARS-CoV-2 Recombinant Spike Protein-based Vaccine: A Promising Candidate against the Recent Imperial Coronavirus Disease (COVID-19) |
4377 |
| Scientific publishing in the COVID-19 era: successes and pitfalls |
4378 |
| Sequencing the Complete Genome of COVID-19 Virus from Clinical Samples Using the Sanger Method |
4379 |
| Severe Acute Respiratory Syndrome Coronavirus 2: From Gene Structure to Pathogenic Mechanisms and Potential Therapy |
4380 |
| Six feet apart or six feet under: The impact of COVID-19 on the Black community |
4381 |
| Social Distancing Causally Impacts the Spread of SARS-CoV-2: A U.S. Nationwide Event Study |
4382 |
| Spinal Epidural Abscess in COVID-19 patients |
4383 |
| Spotlight on child abuse and neglect response in the time of COVID-19 |
4384 |
| Spreading of infections on random graphs: A percolation-type model for COVID-19 |
4385 |
| Standard operating procedures for SARS-CoV-2 detection by a clinical diagnostic RT-LAMP assay |
4386 |
| Statins linked to lower risk of death from COVID-19, study suggests |
4387 |
| Strong Correlation Between Prevalence of Severe Vitamin D Deficiency and Population Mortality Rate from COVID-19 in Europe |
4388 |
| Subcutaneous terbutaline as an alternative tometered-dose inhalers for asthma during the COVID-19 pandemic |
4389 |
| Subcutaneous tocilizumab treatment in patients with severe COVID-19 related cytokine release hyndrome: An observational cohort study |
4390 |
| Successful use of tPA for thrombolysis in COVID related ARDS: a case series |
4391 |
| Superior anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study |
4392 |
| Surfing the COVID-19 scientific wave |
4393 |
| Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies |
4394 |
| Telehealth and humanism: unexpected partnership forged during COVID-19 |
4395 |
| Testing COVID-19 tests faces methodological challenges |
4396 |
| The Anxiety Disorder Among the Healthcare Providers During The COVID-19 Infection Pandemic: A Systematic Review |
4397 |
| The British ‘U-turn’ – yetis Herd Immunity still the solution to COVID 19? |
4398 |
| The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study |
4399 |
| The Emergent Pandemic- A Review on Coronavirus SARS- Cov-2: Virology, Pathogenesis and Outbreak |
4400 |
| The encounter of tumor and SARS-CoV-2- Pathological findings in a patient with colon cancer and COVID-19 |
4401 |
| The future is now: a call for action for cardiac telerehabilitation in the COVID-19 pandemic from the secondary prevention and rehabilitation, section of the European Association of Preventive Cardiology |
4402 |
| The Impact of Major Events on Ongoing Non- inferiority Trials, With Application to COVID-19 |
4403 |
| The Meaning of Care and Ethics to Mitigate the Harshness of Triage in Second-Wave Scenario Planning During the COVID-19 Pandemic |
4404 |
| The network effect: studying COVID-19 pathology with the Human Cell Atlas |
4405 |
| The Novel Coronavirus 2019 (COVID-19): A Narrative Review |
4406 |
| The peripheral lymphocyte count as a predictor of severe COVID-19 and the effect of treatment with ciclesonide |
4407 |
| The proportion and effect of corticosteroid therapy for patients with COVID-19 infection: a systematic review and meta-analysis |
4408 |
| The Role of Age Distribution, Time Lag Between Reporting and Death and Healthcare System Capacity in Case Fatality Estimates of COVID-19 |
4409 |
| The Tricky Math of Herd Immunity for COVID-19 |
4410 |
| The Urgency of Spiritual Care: COVID-19 and the Critical Need for Whole-Person Palliation |
4411 |
| The value of targeting recombination as a strategy against coronavirus diseases |
4412 |
| Thoracic cancer surgery during the COVID-19 pandemic: A consensus statement from the Thoracic Domain of the Asian Society for Cardiovascular and Thoracic Surgery |
4413 |
| Three stages to COVID-19 brain damage, new review suggests |
4414 |
| To comfort always:Are we ignoring this duty in Covid protocols? |
4415 |
| Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus |
4416 |
| Transmission of SARS-CoV-2 via fecal-oral and aerosols–borne routes: Environmental dynamics and implications for wastewater management in underprivileged societies |
4417 |
| Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis |
4418 |
| Type 1 diabetes onset triggered by COVID-19 |
4419 |
| Validation and Comparison of a Modified CDC Assay with two Commercially Available Assays for the Detection of SARS-CoV-2 in Respiratory Specimen |
4420 |
| Zoonoses: beyond the human–animal–environment interface |
4421 |
| A pH-dependent switch mediates conformational masking of SARS-CoV-2 spike |
4422 |
| A systematic review of the smartphone applications available for corona virus disease 2019 (COVID19) and their assessment using the mobile app rating scale (MARS). |
4423 |
| Angiotensin-(1-7) and Obesity: Role on cardiorespiratory fitness and COVID-19 implications |
4424 |
| Are Our COVID Warriors Cared-for Enough? A Nationwide Survey on Stress Among Doctors During the COVID-19 Pandemic |
4425 |
| Are we fully exploiting type I Interferons in today’s fight against COVID-19 pandemic? |
4426 |
| Association of Comorbidities with Coronavirus Disease 2019: A Review |
4427 |
| Association of SARS-CoV-2 Genomic Load with COVID-19 Patient Outcomes |
4428 |
| Association of Sickle Cell Trait with Risk and Mortality of COVID-19: Results from the UK Biobank |
4429 |
| Characterization of Microbial Co-infections in the Respiratory Tract of hospitalized COVID-19 patients |
4430 |
| Clinical manifestation and neonatal outcomes of pregnant patients with COVID-19 pneumonia in uhan, China |
4431 |
| Computational analysis of the SARS-CoV-2 and other viruses based on the Kolmogorov’s complexity and Shannon’s information theories |
4432 |
| Contingency plan for the intensive care services for the COVID-19 pandemic Plan de contingencia para los servicios de medicina intensive frente a la pandemia COVID-19 |
4433 |
| Correlations between COVID-19 and burden of dementia: An ecological study and review of literature |
4434 |
| Corticosteroid therapy for patients with CoVID-19 pneumonia: a before-after study |
4435 |
| COVID‑19 and child and adolescent psychiatry: an unexpected blessing for part of our population? |
4436 |
| COVID‑19 epidemic and public mental health care in Italy: ethical considerations |
4437 |
| Covid-19 exposure risk for family members of healthcare workers: an observational study |
4438 |
| COVID-19 Infection: Strategies on When to Discontinue Isolation, a retrospective study |
4439 |
| COVID-19 Treatment: Close to a Cure? – A Rapid Review of Pharmacotherapies for the Novel coronavirus |
4440 |
| Development of Autonomous Advanced Disinfection Tunnel to Tackle External Surface Disinfection of COVID‑19 Virus in Public Places |
4441 |
| Dynamic changes of peripheral blood lymphocytes subsets in adult patients with COVID-19 |
4442 |
| Emergency Tracheostomy in Two Airway Trauma Patients Suspected of COVID-19: A Case Report |
4443 |
| The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for healthcare. EnvironmentalWeather Conditions and Influence on Transmission of SARS-CoV-2 |
4444 |
| Estimation of the probable outbreak size of novel coronavirus (COVID-19) in social gathering events and industrial activities |
4445 |
| Evaluation of sex-related hormones and semen characteristics in reproductive-aged male COVID-19 patients |
4446 |
| Exaggerated risk of transmission of COVID-19 by fomites |
4447 |
| Frequency and severity of COVID-19 in multiple sclerosis: a short single-site report from northern Italy. |
4448 |
| Genetic risk factors for death with SARS-CoV-2 from the UK Biobank |
4449 |
| Global change of surgical and oncological clinical practice in urology during early COVID‑19 pandemic |
4450 |
| Heterogeneity in reporting venous thromboembolic phenotypes in COVID-19: Methodological issues and clinical implications |
4451 |
| Highly predictive regression model of active cases of COVID-19 in a population by screening wastewater viral load |
4452 |
| Impact of anxiety associated with COVID-19 on tinnitus |
4453 |
| Infection risks faced by public health laboratory services teams when handling specimens associated with COVID-19 |
4454 |
| Initial emergency department mechanical ventilation strategies for COVID-19 hypoxemic respiratory failure and ARDS |
4455 |
| MENTAL HEALTH CONCERN DURING COVID-19 PANDEMIC IN NEPAL |
4456 |
| Off‑the‑shelf barrier for emergency intubation in the cardiac catheterization laboratory during the coronavirus disease 2019 (COVID‑19) pandemic |
4457 |
| Optimal sample pooling: an efficient tool against SARS-CoV-2 |
4458 |
| Pathologic Features of COVID-19: A Concise Review |
4459 |
| Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents |
4460 |
| Potential effective treatment for COVID-19: systematic review and meta-analysis of the severe infectious disease with convalescent plasma therapy |
4461 |
| Pre‑existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID‑19 Liver Injury Spectrum Study) |
4462 |
| Pregnancy with Covid-19: Management considerations for care of severe and critically ill cases |
4463 |
| Recent insights for the emerging COVID-19: drug discovery, therapeutic options and vaccine development |
4464 |
| RELATION OF DIETARY FACTORS WITH INFECTION AND MORTALITY RATES OF COVID-19 ACROSS THE WORLD |
4465 |
| Role of Chest Radiographs during COVID-19 Pandemic |
4466 |
| Evaluation of COVID-19 based on ACE2 expression in normal and cancer patients |
4467 |
| Herd Immunity” Controlled and Planned versus Uncontrolled and Random, in the strategy to fight against COVID 19: An option with Live Pathogen Virus Vaccine |
4468 |
| “Viral” Spread of COVID-19: The Digital World Reflects and Precedes Reality |
4469 |
| COVID-19 and cancer |
4470 |
| Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding |
4471 |
| A Conversation about COVID-19with Economists, Sociologists, Statisticians, and Operations Researchers |
4472 |
| Coronavirus vaccine developers wary of errant antibodies |
4473 |
| A Multinational Pilot Study on the Lived Experiences and Mental Health Impacts from the COVID-19 Pandemic |
4474 |
| A one-step, one-tube real-time RT-PCR based assay with an automated analysis for detection of SARS-CoV-2 |
4475 |
| A rational approach to identifying effective combined anticoronaviral therapies against feline coronavirus |
4476 |
| A Retrospective Review of Memantine Use and COVID-19- associated Mortality from a National database |
4477 |
| A Review on Coronavirus Disease 2019 (COVID-19) in Pediatric Patients |
4478 |
| Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study |
4479 |
| Air and surface contamination in non-health care settings among 641environmental specimens of 39 COVID-19 cases |
4480 |
| An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment |
4481 |
| An update on origin of SARS-CoV-2: Despite closest identity, bat (RaTG13) and Pangolin derived Coronaviruses varied in the critical binding site and O-linked glycan residues |
4482 |
| Another invisible enemy indoors: COVID-19, human health, the home, and United States indoor air policy |
4483 |
| Are Genetic Vaccines the Right Weapon against COVID-19? |
4484 |
| Arterial and venous strokes in the setting of COVID-19 |
4485 |
| Assessing SARS-CoV-2 RNA levels and lymphocyte/T cell counts in COVID-19 patients revealed initial immune status as a major determinant of disease severity |
4486 |
| Assessment of patients who tested positive for COVID-19 after recovery |
4487 |
| Assessment of SARS-CoV-2 Specific CD4(+) and CD8 (+) T Cell Responses Using MHC Class I and II tetramers |
4488 |
| ASSOCIATION BETWEEN ACUTE PANCREATITIS AND COVID-19: COULD PANCREATITIS BE THE MISSING PIECE OF THE PUZZLE ABOUT INCREASED MORTALITY RATES? |
4489 |
Association of immunological features with COVID-
19 severity: a systematic review and meta-analysis |
4490 |
| The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings |
4491 |
| BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine? |
4492 |
| Images in Clinical Tropical Medicine Bulla Formation and Tension Pneumothorax in a Patient with COVID-19 |
4493 |
| Case Report: COVID-19–Related Pneumothorax—Case Series Highlighting a Significant Complication |
4494 |
| Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a retrospective case study in four hospitals in Italy, Spain and the Netherlands |
4495 |
| Co-infection, co-epidemics of Covid-19 and Dengue in dengue endemic countries: a serious health concern |
4496 |
| Complete protection from covid-19 is possible for health workers All they need is the right protective equipment |
4497 |
| Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position |
4498 |
| Continuous flexibility analysis of SARS-CoV-2 Spike prefusion structures |
4499 |
Convalescent plasma therapy in patients with COVID-19
|
4500 |
COVID and consent
|
4501 |
| COVID-19: A CENTENNIAL PANDEMIC FROM ORIGIN TO CLINICAL TRIALS |
4502 |
| Covid-19: Airborne transmission is being underestimated, warn experts |
4503 |
| COVID-19 and HIV co-infection an emerging consensus |
4504 |
COVID-19 and tuberculosis
|
4505 |
| COVID-19 Clinical Diagnostics and Testing Technology |
4506 |
| COVID-19: Focus on masks and respirators – Implications for oral health-care workers |
4507 |
| COVID-19: Implications, Reactions and Future Directions |
4508 |
| CoVid-19 Pandemic Trend Modeling and Analysis to Support Resilience Decision-Making |
4509 |
| COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus |
4510 |
| COVID-19 spurs wave of innovative diagnostics |
4511 |
| COVID-19: the worst may be yet to come |
4512 |
| COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted? |
4513 |
| Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper |
4514 |
| D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study |
4515 |
| Debate on Bacille Calmette-Guérin vaccination against COVID-19: Is it worth performing clinical trials? |
4516 |
| Decline of humoral responses against SARS-CoV-2 Spike in convalescent individuals |
4517 |
| Disappearance of Antibodies to SARS-Associated Coronavirus after Recovery |
4518 |
| Disappearance of antibodies to SARS-CoV-2 in a Covid-19 patient after recovery |
4519 |
| Disequilibrium Propagation of Quantity Constraints: Application to the COVID lockdowns |
4520 |
| Do Pre-existing Anxiety-Related and Mood Disorders Differentially Impact COVID-19 Stress Responses and Coping? |
4521 |
| Does COVID-19 cause permanent damage to olfactory and gustatory func‐ tion? |
4522 |
| Double-quencher probes improve detection sensitivity toward Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a reverse-transcription polymerase chain reaction (RT-PCR) assay |
4523 |
| Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike |
4524 |
| Effects of lockdown on human sleep and chronotype during the COVID-19 pandemic |
4525 |
| Emerging Neurology of COVID-19 |
4526 |
| Emerging patterns of hypercoagulability associated with critical COVID-19: A review |
4527 |
| Encephalomyelitis associated with Covid-19 infection: case report |
4528 |
| Erythema nodosum as a cutaneous manifestation of COVID-19 infection |
4529 |
| European consensus recommendations for neonatal and paediatric retrievals of positive or suspected COVID-19 patients |
4530 |
| Existential Givens in the COVID-19 Crisis |
4531 |
| Expert consensus on prevention and control of COVID-19 in the neurological intensive care unit (first edition) |
4532 |
| Extracellular vesicles containing ACE2 efficiently prevent infection by SARS- CoV-2 Spike protein-containing virus |
4533 |
| What we’re trying to do is make concrete a bit like a biological system, so it can detect damage and then heal itself.” |
4534 |
| Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities |
4535 |
| Guillain-Barré syndrome associated with COVID-19 infection: a case from the UK |
4536 |
| Human B cell clonal expansion and convergent antibody responses to SARS- CoV-2 |
4537 |
| Human iPSC-Derived Cardiomyocytes , are Susceptible to SARS-CoV-2 Infection |
4538 |
| Immunological and inflammatory profiles in mild and severe cases of COVID-19 |
4539 |
| In vivo structural characterization of the whole SARS-CoV-2 RNA genome identifies host cell target roteins vulnerable to re-purposed drugs |
4540 |
| Infectivity, virulence, pathogenicity, host-pathogen interactions of SARS and SARS-CoV-2 in experimental animals: a systematic review |
4541 |
| Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study |
4542 |
| Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomized controlled trial |
4543 |
| Iranian Emotional Experience and Expression During the COVID-19 Crisis |
4544 |
| Is hydroxychloroquine beneficial for COVID-19 patients? |
4545 |
| Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review |
4546 |
| Kinetics of viral load and antibody response in relation to COVID-19 severity |
4547 |
| Lockdown rollback checklist: Do countries meet WHO recommendations for rolling back lockdown? |
4548 |
| Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients |
4549 |
| Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia |
4550 |
| Mediastinal germ cell tumour during the COVID-19 pandemic |
4551 |
| Mild COVID‑19 infection in an NMO patient treated with tocilizumab: a confirmation of anti‑IL‑6 protective role? |
4552 |
| Molecular architecture of the SARS-CoV-2 virus |
4553 |
| Natural protection of ocular surface from viral infections – a hypothesis |
4554 |
| Neurological immunotherapy in the era of COVID-19 — looking for consensus in the literature |
4555 |
| IMMEDIATE ONLINE ACCEPTED (IOA) ARTICLE |
4556 |
| Novel Stem Cells and Nucleic Acid-Based Vaccine Trials Against Viral Outbreak: A Systematic Evaluation During COVID-2019 Pandemic |
4557 |
| Obesity and COVID-19: a call for action from people living with obesity |
4558 |
| OpenSAFELY: factors associatedwith COVID-19death in 17 millionpatients |
4559 |
| Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers |
4560 |
| Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV epidemic |
4561 |
| Predictive criteria of severe cases in COVID-19 patients of early stage |
4562 |
| Preparing for Pandemics: RNA Vaccines at the Forefront |
4563 |
| Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic. A prospective cohort study |
4564 |
| Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study |
4565 |
| Problems and solutions of personal protective equipment doffing in COVID-19 |
4566 |
| Prospective vaccination of COVID-19 using shRNA-plasmid-LDH nanocon‐ jugate |
4567 |
| Psychological and Behavioural Responses to Coronavirus Disease 2019: The Role of Personality |
4568 |
| Pulmonary alveolar regeneration in adult COVID-19 patients |
4569 |
| Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein |
4570 |
| Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock |
4571 |
| Retraction and republication: cardiac toxicity of hydroxychloroquine in COVID-19 |
4572 |
| Review of the Chest CT Differential Diagnosis of Ground-Glass Opacities in the COVID Era |
4573 |
| RNA-dependent RNA Polymerase of SARS-CoV-2 as a Therapeutic Target |
4574 |
| Role of Immune Dysregulation in Increased Mortality Among a Specific Subset of COVID-19 Patients and Immune-Enhancement Strategies for Combatting Through Nutritional Supplements |
4575 |
| SARS-CoV-2 cytopathogenesis in cultured cells and in COVID-19 autoptic lung, evidences of lipid involvement. |
4576 |
| SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study |
4577 |
| SARS-CoV-2 infection in conjunctival tissue |
4578 |
| SARS-CoV-2 may not aggravate liver injury in patients with hepatitis B virus infection -Manuscript Draft |
4579 |
| SARS-CoV-2 Origins and Evolution: Insights from Coronaviruses Recombination and Phylogenetic Analysis |
4580 |
| SARS-CoV-2 seroprevalence in COVID-19 hotspots |
4581 |
| SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy |
4582 |
| SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings |
4583 |
| Sixmonthsof coronavirus: themysteries scientistsare still racing to solve |
4584 |
| Screening and testing for a suitable untransfected cell line for SARS-CoV-2 studies |
4585 |
| Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice |
4586 |
| Sentiments and emotions evoked by news headlines of coronavirus disease (COVID-19) outbreak |
4587 |
| Serum KL-6 can distinguish between different phenotypes of severe COVID-19 |
4588 |
| Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer |
4589 |
| Special section on ‘Sociology and the Coronavirus (COVID-19) Pandemic’ |
4590 |
| Structural basis for helicase-polymerase coupling in the SARS-CoV-2 replication- transcription complex |
4591 |
| Sustainability in a COVID-19 world |
4592 |
| Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19 |
4593 |
| Tackling COVID-19 Pandemic through Nanocoatings: Confront and Exactitude |
4594 |
| Temporal Change of SARS-CoV-2 in Clinical Specimens of COVID-19 Pneumonia Patients |
4595 |
| That Escalated Quickly: Remdesivir’s Place in Therapy for COVID-19 |
4596 |
| The application of corticosteroids in COVID-19: A two-edged sword |
4597 |
| The clinical course of SARS-CoV-2 positive neonates |
4598 |
| The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2 |
4599 |
| The World Goes Bats: Living Longer and Tolerating Viruses |
4600 |
| Too bored to bother? Boredom as a potential threat to the efficacy of pandemic containment measures |
4601 |
| Towards the design of multiepitope-based peptide vaccine candidate against SARS-CoV-2 |
4602 |
| Transmission Routes Analysis of SARS-CoV-2: A Systematic Review and Case Report |
4603 |
| Update on neurological manifestations of COVID-19 |
4604 |
| US withdrawal fromWHO is unlawful and threatens global and US health and security |
4605 |
| Viral shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2 |
4606 |
| What does the future hold for the workforce of tomorrow? |
4607 |
| Why Companion Animals Are Beneficial During COVID-19 Pandemic |
4608 |
| Will the COVID-19 pandemic worsen the obesity epidemic? |
4609 |
| Work based concerns and personal implications of COVID-19 |
4610 |
| Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia |
4611 |
| An adult presentation consistent with PIMS-TS |
4612 |
| Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT–qPCR primer–probe sets |
4613 |
| Assessing the Impact of COVID-19 on the management of patients with liver diseases: A national survey by the Italian Association for the Study of the Liver |
4614 |
| Caution in Identifying Coronaviruses by Electron Microscopy |
4615 |
| Clinical features in 52 patients with COVID-19 who have increased leukocyte count: a retrospective analysis |
4616 |
| Coagulation disorder in COVID-19 |
4617 |
| Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with sARS-CoV-2 pneumonia: an opportunistic retrospective analysis |
4618 |
| Comprehensive in-vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms |
4619 |
| COVID-19 and liver transplantation |
4620 |
| COVID-19 and Racism—a double edged dagger |
4621 |
| COVID-19 in Children with Nephrotic Syndrome on Anti-CD20 Chronic Immunosuppression |
4622 |
| COVID-19 pandemic highlights racial health inequities |
4623 |
| COVID-19 Presented with Gastrointestinal Manifestations in an 11-Days-Old Neonate: A Case Report and Review of the Literature |
4624 |
| COVID-19: review and hematologic impact |
4625 |
| COVID-19-associated acute cerebral venous thrombosis: clinical, CT, MRI and EEG features |
4626 |
| Cytokine prediction of mortality in COVID19 patients |
4627 |
| Declined serum high density lipoprotein cholesterol is associated with the se- verity of COVID-19 infection |
4628 |
| Discovery of clinically approved drugs capable of inhibiting SARS-CoV-2 in vitro infection using a henotypic screening strategy and network-analysis to predict their potential to treat covid-19 |
4629 |
| Discriminating Mild from Critical COVID-19 by Innate and Adaptive Immune Single-cell Profiling of Bronchoalveolar Lavages |
4630 |
| Do We Need a Coronavirus (Safeguards) Act 2020? Proposed Legal Safeguards for Digital Contact Tracing and Other Apps in the COVID-19 Crisis |
4631 |
| Evaluating the evidence for direct central nervous system invasion in patients infected with the nCOVID-19 virus |
4632 |
| Extrapulmonary manifestations of COVID-19 |
4633 |
| Fighting COVID-19: Integrated Micro- and Nanosystems for Viral Infection Diagnostics |
4634 |
| Genome-wide analysis of Indian SARS-CoV-2 genomes for the identification of genetic mutation and SNP |
4635 |
| Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus) |
4636 |
| Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID- 19: a retrospective cohort study |
4637 |
| Iloprost for COVID-19-related vasculopathy |
4638 |
| Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19 |
4639 |
| Inactivation analysis of SARS-CoV-2 by specimen transport media, nucleic acid extraction reagents, detergents and fixatives |
4640 |
| Inflammatory olfactory neuropathy in two patients with COVID-19 |
4641 |
| Information System Design COVID-19 with Prototype Model |
4642 |
| Involvement of Spike Protein, Furin, and ACE2 in SARS-CoV-2-Related Cardiovascular Complications |
4643 |
| Locked-In with COVID-19 |
4644 |
| Long-term infection of SARS-CoV-2 changed the body's immune status |
4645 |
| Machine Learning Approaches in COVID-19 Survival Analysis and Discharge Time Likelihood Prediction using Clinical Data |
4646 |
| Machine learning for COVID-19—asking the right questions |
4647 |
| Molecular analysis of binding region of an ACE2 as a receptor for SARS-CoV-2 between humans and mammals |
4648 |
| Organisations for patients with cancer feel the brunt of COVID-19 pandemic |
4649 |
| Pregnancy Treatment in Covid-19 Pandemic: General Considerations |
4650 |
| Prevalence of positive COVID-19 among asymptomatic health care workers who care patients infected with the novel coronavirus: A retrospective study |
4651 |
| Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19) |
4652 |
| QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin |
4653 |
| Recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case report |
4654 |
| Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis |
4655 |
| Robust three-dimensional expansion of human adult alveolar stem cells and SARS-CoV-2 infection |
4656 |
| SARS-CoV-2 and Cancer: are they really partners in crime ? |
4657 |
| SARS-CoV-2 host cell entry might involve Beta adrenergic receptors |
4658 |
| SARS-CoV-2 induces activation and diversification of human plasmacytoid pre-dendritic cells |
4659 |
| SARS-CoV-2 infection in the lungs of human ACE2 transgenic mice causes severe inflammation, immune cell infiltration, and compromised respiratory function |
4660 |
| Severe refractory Kawasaki disease in seven infants in the COVID-19 era |
4661 |
| Severely ill COVID-19 patients display augmented functional properties in SARS-CoV-2-reactive CD8+ T cells |
4662 |
| A Strategy to Treat COVID-19 Disease with Targeted Delivery of Inhalable Liposomal hydroxychloroquine: A Non-clinical Pharmacokinetic Study |
4663 |
| Structure-based drug designing towards the identification of potential anti-viral for COVID-19 by targeting endoribonuclease NSP15 |
4664 |
| The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19 |
4665 |
| The use of gastric lavage in reducing COVID-19 fever: A narrative review |
4666 |
| Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19 |
4667 |
| Uterine Fibroid Embolization in time of Covid-19 |
4668 |
| Which animals are at risk? Predicting species susceptibility to Covid-19 |
4669 |
| Addition of Tocilizumab to standard of care reduces mortality in severe COVID-19: A systematic review and meta-analysis |
4670 |
| Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use Among Outpatients Diagnosed with COVID-19 |
4671 |
| Association of Cancer with Risk and Mortality of COVID-19: Results from the UK Biobank |
4672 |
| Bilateral spontaneous pneumothorax in SARS-CoV-2 infection: A very rare, life-threatening complication |
4673 |
| Blood cell counts and lymphocyte subsets of patients admitted during the COVID-19 pandemic: a prospective cohort study |
4674 |
| Blood type and outcomes in patients with COVID-19 |
4675 |
| Can interferons stop COVID-19 before it takes hold? |
4676 |
| Cardiac manifestations in COVID‐19 patients—A systematic review |
4677 |
| Clinical Characteristics of Pregnant Women with Coronavirus Disease 2019 in Wuhan, China |
4678 |
| Commercial Serology Assays Predict Neutralization Activity Against SARS-CoV-2 |
4679 |
| Comparison of deep learning approaches to predict COVID-19 infection |
4680 |
| Compensation effect between deaths from COVID-19 and crashes: The ITALIAN CASE |
4681 |
| COVID-19 - Considerations for the female athlete |
4682 |
| COVID-19 Complicated by Massive Acute Pulmonary Embolism: A Case Report |
4683 |
| COVID-19 pandemic: new rules of engagement in endocrine surgery |
4684 |
| COVID-19 screening during fertility treatment: how do guidelines compare against each other? |
4685 |
| Decreased serum levels of inflammaging marker miR-146a are associated with clinical response to tocilizumab in COVID-19 patients |
4686 |
| The Coronavirus Collective How I overcame COVID-19 infection and went on to defeat the surge by working in Intensive Care |
4687 |
| Development and execution of a pandemic preparedness plan: Therapeutic medical physics and radiation dosimetry during the COVID‐19 crisis |
4688 |
| Diagnosis of COVID-19 using CT scan images and deep learning techniques |
4689 |
| Diagnostic value of skin manifestation of SARS-CoV-2 infection |
4690 |
| Do lifestyle changes of renal transplant recipients during the pandemic reduce the risk of COVID-19? |
4691 |
| Dynamic Model of COVID-19 Disease with Exploratory Data Analysis |
4692 |
| Early percutaneous tracheostomy for patients with COVID-19 |
4693 |
| Estimating the Effect of Social Distancing Interventions on COVID-19 in the United States |
4694 |
| Fetal deaths in pregnancies with SARS-COV-2 infection in Brazil: A case series |
4695 |
| First expert elicitation of knowledge on drivers of emergence of the COVID-19 in pets |
4696 |
| Fractal Signatures of the COVID-19 spread |
4697 |
| Frequency and outcome of olfactory impairment and sinonasal involvement in hospitalized patients with COVID-19 |
4698 |
| Frugal solutions for the operating room during the COVID-19 |
4699 |
| GEICAM Guidelines for the Management of Patients with Breast Cancer During Spain’s COVID-19 Pandemic |
4700 |
| Identifying SARS-CoV-2 entry inhibitors through drug repurposing screens of SARS- S and MERS-S pseudotyped particles |
4701 |
| In-house modification and improvement of the CDC real-time PCR diagnostic assay for SARS-CoV-2 detection. |
4702 |
| Recommendations and Resources for Clinical Ultrasound Education During the COVID-19 Era. |
4703 |
| Long-term suicide prevention during and after the COVID-19 epidemic |
4704 |
| Low Rate of COVID-19 pneumonia in Kidney Transplant Recipients - A Battle Between Infection and Immune Response? |
4705 |
| Misinformation sharing and social media fatigue during COVID-19: An affordance and cognitive load perspective |
4706 |
| Monitoring antibody response following SARS-CoV-2 infection: Diagnostic efficiency of four automated immunoassays |
4707 |
| Papillary Muscle Rupture Due to Delayed STEMI Presentation in a Patient Self- Isolating for Presumed COVID-19 |
4708 |
| Personalizing vulvar cancer workflow in COVID‑19 era: a proposal from Vul.Can MDT |
4709 |
| Pharmacologic management of patients with hepatic and pancreatic diseases that involve immunosuppressive therapies. Position statement within the framework of the SARS-CoV-2 (COVID-19) pandemic |
4710 |
| Platelets to surrogate lung inflammation in COVID-19 Patients |
4711 |
| Population Genetics of SARS-CoV-2: Disentangling Effects of Sampling Bias and Infection Clusters |
4712 |
| Potential Trends for COVID-19 Fighting: An Immuno-informatics Overview |
4713 |
| Predictive performance of SOFA and qSOFA for in-hospital mortality in severe novel coronavirus disease |
4714 |
| Psychometric Testing of Three COVID-19-Related Scales Among People with Mental Illness |
4715 |
| Public Awareness of Nature and the Environment During the COVID‑19 Crisis |
4716 |
| Review of Indoor Aerosol Generation, Transport and Control in the Context of COVID-19 |
4717 |
| Use of tocilizumab in kidney transplant recipients with COVID-19 |
4718 |
| Serological Tests for SARS-CoV-2 Coronavirus by Commercially Available Point-of-Care and Laboratory Diagnostics in Pre-COVID-19 Samples in Japan |
4719 |
| Serology in Children with Multisystem Inflammatory Syndrome (MIS-C) associated with COVID-19 |
4720 |
| Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders |
4721 |
| Social isolation due to the COVID-19 pandemic has led to worse outcomes in females with inflammatory arthritis |
4722 |
| Societal heterogeneity contributes to complex dynamic patterns of the COVID-19 pandemics: insights from a novel Stochastic Heterogeneous Epidemic Model (SHEM) |
4723 |
| STIs and the COVID-19 pandemic: the lockdown does not stop sexual infections |
4724 |
| Strategies for Managing the Impacts of Disruptions During COVID-19: an Example of Toilet Paper |
4725 |
| Successful coronary artery bypass operation inaSARS‐COV‐2 infected patient with acute coronary syndrome |
4726 |
| Tackling the cytokine storm in COVID-19, challenges, and hopes |
4727 |
| The add-on effect of Chinese herbal medicine on COVID-19: a systematic review and meta-analysis |
4728 |
| The Age Pattern of the Male- to- Female Ratio in Mortality from COVID-19 Mirrors that of Cardiovascular Disease but not Cancer in the General Population |
4729 |
| The care of kidney transplant recipients during a global pandemic: Challenges and strategies for success |
4730 |
| The impact of SARS-CoV-2 on surgical education – challenges and potential solutions |
4731 |
| The peer review at high risk from COVID-19 – are we socially distancing from scientific quality control? |
4732 |
| The recent challenges of highly contagious COVID-19; causing respiratory infections: symptoms, diagnosis, transmission, possible vaccines, animal models and immunotherapy |
4733 |
| Thinking strategically for COVID‐19: suppress and lift, to flatten or to crush? |
4734 |
| Thrombosis and coagulopathy in COVID-19: An illustrated review |
4735 |
| Undocumented infectives in the Covid-19 pandemic |
4736 |
| Use of tocilizumab in kidney transplant recipients with COVID-19 |
4737 |
| Using simulation to assess the potential effectiveness of implementing screening at national borders during international outbreaks of influenza, SARS, Ebola virus disease and COVID-19 |
4738 |
| Vaccines based on Virus-Like nano-Particles for use against Middle East Res- piratory Syndrome (MERS) coronavirus |
4739 |
| Varying Presentations and Favourable Outcomes of COVID-19 Infection in Children and Young Adults with Sickle Cell Disease: An Additional Case Series with Comparisons to Published Cases |
4740 |
| WHO’s Covid-19 inquiry is a shrewd move in a sea of disinformation |
4741 |
| γ-Glutamyltransferase Elevations Are Frequent in Patients With COVID-19: A Clinical Epidemiologic Study |
4742 |
| A crisis of accountability for women’s, children’s, and adolescents’ health |
4743 |
| A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology |
4744 |
| A literature review of 2019 novel coronavirus (SARS-CoV2) infection in neonates and children |
4745 |
| A projection for psychiatry in the post-COVID-19 era: potential trends, challenges, and directions |
4746 |
| ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population |
4747 |
| An mRNA Vaccine against SARS-CoV-2 — Preliminary Report |
4748 |
| Point of care nucleic acid testing for SARS-CoV-2 in hospitalised patients: a clinical validation trial and implementation study. |
4749 |
| Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS- CoV-2 RNA Polymerase in Mice |
4750 |
| Assessment of Evidence for COVID-19-Related Treatments: Updated 7/2/2020 |
4751 |
| Challenges and issues of SARS-CoV-2 pool testing |
4752 |
| Challenges and issues of SARS-CoV-2 pool testing |
4753 |
| Challenges and issues of SARS-CoV-2 pool testing |
4754 |
| Challenges and issues of SARS-CoV-2 pool testing |
4755 |
| Comprehensive mapping of immune perturbations associated with severe COVID-19 |
4756 |
| Coronavirus: Six types of COVID-19 identified by scientists in 'major' breakthrough for treatment Symptoms not widely linked to the virus - like confusion and abdominal pain - are found to be hallmarks of its most severe forms. |
4757 |
| Covid-19 and breastfeeding: what’s the risk? |
4758 |
Covid-19 and Disparities in Nutrition and Obesity
|
4759 |
| COVID-19 vaccine development and a potential nanomaterial path forward |
4760 |
| COVID-19: from rapid genome sequencing to fast decisions |
4761 |
| Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein |
4762 |
| SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses |
4763 |
| Dexamethasone for COVID-19: data needed from randomized clinical trials in Africa |
4764 |
| Fetal alcohol spectrum disorders: preventing collateral damage from COVID-19 |
4765 |
| How mental health care should change as a consequence of the COVID-19 pandemic |
4766 |
| Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19 |
4767 |
| Investigating Ketone Bodies as Immunometabolic Countermeasures against Respiratory Viral Infections |
4768 |
| Lessons for COVID-19 immunity from other coronavirus infections |
4769 |
| Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection |
4770 |
| Offline: COVID-19 and the dangers of Sinophobia |
4771 |
| Can activation of NRF2 be a strategy against COVID-19? |
4772 |
| COVID-19 infection: mitohormetic concept of immune response |
4773 |
| Towards pandemic preparedness beyond COVID-19 |
4774 |
| Use of MELD scores in alcoholic hepatitis |
4775 |
| Racial Health Disparities and Covid-19 — Caution and Context |
4776 |
| Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands |
4777 |
| Recurrence of positive SARS‑CoV‑2 viral RNA in recoveredCOVID‑19 patients during medical isolation iobservation |
4778 |
| SARS‑CoV‑2 failure to infect or replicate in mosquitoes: an extreme challenge |
4779 |
| Survivorship after COVID-19 ICU stay |
4780 |
| Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection |
4781 |
| Tackling cervical cancer in Europe amidst the COVID-19 pandemic |
4782 |
| The Climate Crisis and Covid-19 — A Major Threat to the Pandemic Response |
4783 |
| Transplacental transmission of SARS-CoV-2 infection |
4784 |
| Using Serology with Models to Clarify the Trajectory of the SARS-CoV-2 Emerging Outbreak |
4785 |
| Validation of virtual reality orbitometry bridges digital and physical worlds |
4786 |
| WHO’s Next— The United States and the World Health Organization |
4787 |
| A COVID-19 patient with multiple negative results for PCR assays outside Wuhan, China: a case report |
4788 |
| A Hawkes process model for the propagation of COVID-19: simple analytical results |
4789 |
| A neonate born to mother with COVID-19 during Pregnancy & HELLP syndrome: A possible vertical transmission |
4790 |
| A Novel Approach to Calculate the Case Fatality Rate of COVID-19 in European countries |
4791 |
| A Novel Severity Score to Predict Inpatient Mortality in COVID-19 patients |
4792 |
| A single intranasal dose of chimpanzee adenovirus-vectored vaccine confers sterilizing immunity against SARS-CoV-2 infection |
4793 |
| A systematic review uncovers a wide-gap between COVID-19 in humans and animal models |
4794 |
| ABO polymorphism and SARS-CoV-2 infection - a meta-analysis |
4795 |
| Acute Demyelinating Encephalomyelitis (ADEM) in COVID-19 infection- A Case Series. |
4796 |
| Age- and sex-transcriptome analysis provide evidences for the sex biases in the pathogenesis of COVID-19 and other respiratory infectious diseases |
4797 |
| Covid-19 Kills More Men Than Women: An Overview of Possible Reasons |
4798 |
| Anti-SARS-CoV-2 IgG antibodies in adolescent students and their teachers in Saxony, Germany (SchoolCoviDD19): very low seropraevalence and transmission rates |
4799 |
| Antiviral mouthwashes: possible benefit for COVID-19 with evidence-based approach |
4800 |
| Antiviral treatment of COVID-19: a clinical pharmacology narrative review |
4801 |
| Assessing the impact of coordinated COVID-19 exit strategies across Europe |
4802 |
| Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19 |
4803 |
| Blood biochemical characteristics of patients with coronavirus disease 2019 (COVID-19): a systemic review and meta-analysis |
4804 |
| Calming the Cytokine Storm - Splenic Ultrasound for Treating Inflammatory Disorders and Potentially COVID-19 |
4805 |
| Clinical characteristics of children and young people hospitalised with covid-19 in the United Kingdom: prospective multicentre observational cohort study |
4806 |
| Confirmed central olfactory system lesions on brain MRI in COVID-19 patients with anosmia: a case-series |
4807 |
Coronavirus Disease-19 and Cardiovascular Disease
|
4808 |
| COVID-19 and Children With Down Syndrome: is There Any Real Reason to Worry? Case Report |
4809 |
| COVID-19 clinical implications: the significance of nanomedicine |
4810 |
| COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation |
4811 |
| COVID-19 in people with diabetes: understanding the reasons for worse outcomes |
4812 |
| COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation |
4813 |
| Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19 |
4814 |
| Update regarding the possible use of CytoSorb as adjuvant therapy in patients with Covid-19/ novel Coronavirus (Sars-CoV-2) infections |
4815 |
| Development of a simple in vitro assay to identify and evaluate nucleotide analogs against SARS-CoV-2 RNA-dependent RNA polymerase |
4816 |
| Dynamics and future of SARS-CoV-2 in the human host |
4817 |
| Endpoints for randomized controlled clinical trials for COVID-19 treatments |
4818 |
| Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: comparison of nine tests in relation with clinical data |
4819 |
| Evidence about the Chest CT diagnostic performance in the pandemic of SARS-CoV-2 infection: A smooth takeoff and hard landing. |
4820 |
| Face mask use among individuals who are not medically diagnosed with COVID-19: A lack of evidence for and against and implications around public health recommendations |
4821 |
| Gastrointestinal Aspects of COVID-19: A Review |
4822 |
| Planning for Coronavirus People of any age who have serious health issues such as diabetes might be at higher risk for severe illness from COVID-19, the new coronavirus disease that is now a global pandemic. There is plenty you can do to protect yourself, |
4823 |
| Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-throughput Screening |
4824 |
| IgG antibody seroconversion and the clinical progression of COVID-19 pneumonia: A retrospective, cohort study |
4825 |
| Impact of climatic, demographic and disease control factors on the transmission dynamics of COVID-19 in large cities worldwide |
4826 |
| Improving the early diagnosis of suspected patients with COVID-19: a retrospective study of 106 patients |
4827 |
| Increased expression of hypoxia-induced factor 1α mRNA and its related genes in myeloid blood cells from critically ill COVID-19 patients |
4828 |
| Is there a role for blood purification therapies targeting cytokine storm syndrome in critically severe COVID-19 patients? |
4829 |
| Joint CBC-ICT Interpretation for the pre-surgical screening of COVID 19 asymptomatic cases: A cross- sectional study |
4830 |
Lockdown is an effective ‘vaccine’ against COVID-19: A message from India
|
4831 |
| Longitudinal analysis of the humoral response to SARS-CoV-2 spike RBD in convalescent plasma donors |
4832 |
| Longitudinal dynamics of the neutralizing antibody response to SARS-CoV-2 infection |
4833 |
| Multidisciplinary Tracheostomy Quality Improvement in the COVID-19 Pandemic: Building a Global learning Community |
4834 |
| Multiple sclerosis and COVID-19 |
4835 |
| Neurologic and neuroimaging findings in COVID-19 patients: A retrospective multicenter study |
4836 |
| Neutrophils and COVID-19: Nots, NETs, and knots |
4837 |
| Novel Coronavirus Disease (COVID-19): An Update |
4838 |
| Pan-Cancer Analysis Reveals that the SARS-CoV-2 Receptor ACE2 is a Protective Factor for Cancer Progression |
4839 |
| Pathogenesis Clues from the Early Clinical Presentation of 300 Hospitalized COVID-19 Patients |
4840 |
| Potential factors linked to high COVID-19 death rates in British minority ethnic groups |
4841 |
| Prevalence and Impact of Coagulation Dysfunction in COVID-19 in China: A Meta-Analysis |
4842 |
| Progressive worsening of the respiratory and gut microbiome in children during the first two months of COVID-19 |
4843 |
| Qualitative Changes in the SARS-CoV-2 Antibody Response in the Post-Infection Phase Impact the estimates of infections in Population-Based Seroprevalence Studies |
4844 |
| Reconstruction ofthe full transmission dynamics ofCOVID-19 inWuhan |
4845 |
| Remdesivir for the treatment of COVID-19: A living systematic review protocol |
4846 |
| SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months |
4847 |
| SARS-CoV-2 RNA shedding in recovered COVID-19 cases and the presence of antibodies against SARS-CoV-2 in recovered COVID-19 cases and close contacts |
4848 |
| SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection |
4849 |
| SARS-CoV-2 Viral Load is Associated with Increased Disease Severity and Mortality |
4850 |
| SARS-CoV-2-specificTcellimmunity in cases ofCOVID-19andSARS,and uninfected controls |
4851 |
| Serology testing in the COVID-19 pandemic response |
4852 |
| Seroprevalence of SARS-CoV-2 antibodies in an entirely PCR- sampled and quarantined community after a COVID-19 outbreak - the CoNAN study |
4853 |
| Simulations support the interaction of the SARS-CoV-2 spike protein with nicotinic acetylcholine receptors and suggest subtype specificity |
4854 |
| Spiky nanostructures for virus inhibition and infection prevention |
4855 |
| Single-Cell Omics Reveals Dyssynchrony of the Innate and Adaptive Immune System in Progressive COVID-19 |
4856 |
| Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of co‐ ronavirus 3C-like protease enzyme |
4857 |
| Successful treatment of acute heart failure in COVID-19-induced cytokine storm with tocilizumab: a case report |
4858 |
| Systematic modeling of SARS-CoV-2 protein structures |
4859 |
| Tele- Yoga therapy for Patients with Chronic Pain during Covid-19 Lockdown: A Prospective Nonrandomized Single Arm Clinical Trial |
4860 |
| The COVID-19 infodemic |
4861 |
| The Effect of the COVID-19 Pandemic on People with Parkinson’s Disease |
4862 |
| The global impact of the first Coronavirus Disease 2019 (COVID-19) pandemic wave on vascular service |
4863 |
| The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity |
4864 |
| Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis dependent axis |
4865 |
| Ultrasensitive detection of pathogenic viruses with electrochemical biosensor: State of the art |
4866 |
| Upside down solutions: palliative care and COVID-19 |
4867 |
| Vinegar and Its Active Component Acetic Acid Inhibit SARS-CoV-2 Infection In Vitro and Ex Vivo |
4868 |
| Ward renovation and PPE use procedures to protect medical staff from COVID-19 infection |
4869 |
| Virus dissociated from inflammation in fatal COVID-19 |
4870 |
| Critical Care COVID-19 Management Protocol (updated 6-17-2020) |
4871 |
| Tissue-specific tolerance in fatal Covid-19 |
4872 |
| Prior infection by seasonal coronaviruses does not prevent SARS-CoV-2 infection 1 and associated Multisystem Inflammatory Syndrome in children |
4873 |
| Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques |
4874 |
Safety and immunogenicity of the ChAdOx1 nCoV-19
vaccine against SARS-CoV-2: a preliminary report of
a phase 1/2, single-blind, randomised controlled trial
|
4875 |
| COVID-19 No cross- protective immunity in children? |
4876 |
| Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial |
4877 |
| Encouraging results from phase 1/2 COVID-19 vaccine trials |
4878 |
| COVID-19 and Down’s syndrome: are we heading for a disaster? |
4879 |
| COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives |
4880 |
| HOST RESPONSE Can COVID-19 strike twice? |
4881 |
| Antibody tests aren't a COVID-19 panacea. But they're a useful additional tool |
4882 |
| Structural basis of RNA cap modification by SARS-CoV-2 |
4883 |
| Intravenous anakinra for cytokine storm syndromes |
4884 |
| Intravenous anakinra for cytokine storm syndromes |
4885 |
| Intravenous anakinra for cytokine storm syndromes |
4886 |
| Using the right words to address racial disparities in COVID-19 |
4887 |
| Disability and COVID-19: who counts depends on who is counted |
4888 |
| Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population |
4889 |
| Management of diabetes in patients with COVID-19 |
4890 |
| Communicating with children about COVID-19 |
4891 |
| Is baldness a risk factor for Covid-19? Men who have completely lost their hair are 40% more likely to end up in hospital with the virus, study claims |
4892 |
| Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The ‘‘Gabrin sign |
4893 |
| What has the World Health Organization done for us? |
4894 |
| Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19? |
4895 |
| Virus-host interactome and proteomic survey of PBMCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis_compressed |
4896 |
| Utility of COVID-19 Screening in Cancer Patients |
4897 |
| The top 100 most cited articles on COVID-19 |
4898 |
| The time to do serosurveys for COVID-19 is now |
4899 |
| The psychiatric effects of COVID-19 thus far: A review of the current literature |
4900 |
| Strategies to reduce the risk of SARS-CoV-2 re- introduction from international travellers |
4901 |
| SARS-CoV-2 antibodies, serum inflammatory biomarkers 1 and clinical severity of hospitalized COVID-19 Patients |
4902 |
| Remdesivir for COVID-19: match-population analysis with compassionate use of Remdesivir for severe COVID-19 |
4903 |
| Point-of-care serological assays for delayed SARS- coV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study |
4904 |
| Placental barrier against COVID-19 |
4905 |
| Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion |
4906 |
| Particle sizes of infectious aerosols: implications for infection control |
4907 |
| Pandemic science and politics |
4908 |
| Offline: Preparing for a vaccine against COVID-19 |
4909 |
| Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study |
4910 |
| The Conversations We’ve Been Having |
4911 |
| Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential |
4912 |
More Studies are Needed on the Link between Metformin and Decreased Mortality in
Diabetic COVID-19 Patients |
4913 |
| Should Healthcare Workers Wear Masks at Home? |
4914 |
| Management of mother–newborn dyads in the COVID-19 era |
4915 |
| Integrating the evidence: confronting the COVID‑19 elephant |
4916 |
| Hypercoagulability and anticoagulation in patients with COVID-19 requiring renal replacement therapy |
4917 |
| High Viral Load and Poor Ventilation: Cause of High Mortality From COVID-19 |
4918 |
| High incidence of false-positive results of IgG antibody against SARS-CoV-2 with rapid immunochromatographic antibody test due to human common cold coronavirus infection |
4919 |
Herd immunity thresholds for 1 SARS-CoV-2 estimated from
unfolding epidemics |
4920 |
| Harmonisation preserves research resources |
4921 |
Medical Treatment Method of “Bio-robotic esonance and Thermodynamical Interaction” with Analogy of “Frequency – Resonance Setting Formation” on the
Application of “Algorithm for Smart Drugs Controlled by a Bio-robotic System” developed for the “Treatment of Covid-19, Coronavirus and Virus Infections
|
4922 |
| Evidence for immunity to SARS-CoV-2 from epidemiological data series |
4923 |
| Effect of anakinra in COVID-19 |
4924 |
| Effect of anakinra in COVID-19 |
4925 |
| Crosstalk between COVID-19 and prostate cancer |
4926 |
| COVID-19 vaccine affordability and accessibility |
4927 |
| COVID-19 Thrombosis: An Unsolved Mystery |
4928 |
| Covid‑19 mortalityis negatively associated with test number and government effectiveness |
4929 |
| COVID-19: immunopathogenesis and Immunotherapeutics |
4930 |
| COVID-19 and China: lessons and the way forward |
4931 |
| Complement C3 identified as a unique Risk Factor for Disease Severity among Young COVID-19 Patients in Wuhan |
4932 |
| Co-expression of Mitochondrial Genes and ACE2 in Cornea Involved in COVID-19 Infection |
4933 |
| Circulating cytokines andlymphocyte subsets inpatients who have recovered from COVID-19 |
4934 |
| Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia |
4935 |
| Changes in the immune system in patients with Coronavirus Disease-19 (CoViD-19), Caused by SARSCoV- 2 Virus |
4936 |
| Causes and Preventions of Coronavirus (COVID-19) |
4937 |
| Cancer Patients and Risk of Mortality for COVID-19 |
4938 |
| Can favipiravir help in coronavirus treatment? |
4939 |
| Another coronavirus, Another challenge |
4940 |
| Acute Kidney Injury in Patients with the Coronavirus Disease 2019: A Multicenter Study |
4941 |
| A thermostable mRNA vaccine against COVID-19 |
4942 |
| A carbohydrate-binding protein from the edible Lablab beans effectively blocks the infections of influenza viruses and SARS-CoV-2 |
4943 |
| Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions |
4944 |
| Why vaccine rumours stick—and getting them unstuck |
4945 |
| Treatment of COVID-19: Perspective on Convalescent Plasma Transfusion |
4946 |
| The truth is out there, somewhere |
4947 |
| The reproduction number of COVID-19 and its correlation with public health interventions |
4948 |
| The pathophysiology of ‘happy’ hypoxemia in COVID-19 |
4949 |
| The indirect impact of COVID-19 on women Lockdown measures and school closures affect girls and women differently across the world and may have long-term negative consequences.Talha Burki reports. |
4950 |
| The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19) |
4951 |
| The Antiviral Properties of Cyclosporine. Focus on Coronavirus, Hepatitis C Virus, Influenza Virus, and Human Immunodeficiency Virus Infections |
4952 |
| Targeting the cholinergic anti-inflammatory pathway with vagus nerve stimulation in patients with Covid-19? |
4953 |
| Taking responsibility for front-line health-care workers |
4954 |
| Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study |
4955 |
| Rising to the challenge of COVID-19 Ursula Hofer, Andrea Du Toit and Ashley York Scientists around the world have risen to the challenges posed by COVID-19 by rapidly transforming their laboratories and refocusing their research efforts |
4956 |
| Super Resolution-Tex t Image |
4957 |
| Plasma-derived therapy: can the survivors of COVID-19 help the defenseless? |
4958 |
| Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19? |
4959 |
| Pediatric mental and behavioral health in the period of quarantine and social distancing (COVID-19) |
4960 |
| The impact of COVID-19 on hepatitis elimination |
4961 |
| Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications |
4962 |
| Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates |
4963 |
| Mortality in COVID-19 is not merely a question of resource availability |
4964 |
| Managing Children With Renal Diseases During the COVID-19 Pandemic |
4965 |
| Lung fibrosis: an undervalued finding in COVID-19 pathological series |
4966 |
| Longitudinal analyses revealimmunological misfiring in severeCOVID-19 |
4967 |
| Limited Role for Antibiotics in COVID-19: Scarce Evidence of Bacterial Coinfection |
4968 |
| Letter to the editor: Possible role of topical povidone iodine in case of accidental ocular exposure to SARS-CoV-2 |
4969 |
| Impacts of COVID-19 on childhood malnutrition and nutrition-related mortality |
4970 |
| Impact of COVID -19 in cancer patients on severity of disease and fatal outcomes: A systematic review and Meta-Analysis |
4971 |
| Identification of key interactions between SARS‑CoV‑2 main protease and inhibitor drug candidates |
4972 |
| Hyper-inflammatory Syndrome in a ChildWith COVID-19Treated SuccessfullyWith Intravenous Immunoglobulin and Tocilizumab |
4973 |
| Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19 |
4974 |
| Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism |
4975 |
| How to survive Covid-19 even if the vaccine fails |
4976 |
| High prevalence of SARS-CoV-2 and influenza A virus (H1N1) co-infection in dead patients in Northeastern Iran |
4977 |
| Frequency, risk factors, clinical characteristics and outcomes of spontaneous pneumothorax in patients with Covid-19: Results of the UMC-19-S7 |
4978 |
| Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID- 19 pandemic |
4979 |
| Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19 |
4980 |
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
|
4981 |
| Eliminating viral hepatitis in the COVID-19 era:weighing challenge and opportunity |
4982 |
Effect of oral L-Glutamine supplementation on Covid-19 treatment
|
4983 |
| Dynamic changes of liver function parameters in patients with coronavirus disease 2019: A multicenter, retrospective study |
4984 |
| Detection of SARS-CoV-2 from Patient Fecal Samples by Whole Genome Sequencing |
4985 |
| Design of an engineered ACE2 as a novel therapeutics against COVID-19 |
4986 |
| COVID-19: The Hidden Impact on Mental Health and Drug Addiction |
4987 |
| COVID-19 has “devastating” effect on women and girls Natalia Kanem, executive director of theUN Population Fund, is among experts warning about disrupted health services and a surge in gender-based violence. Sophie Cousins reports. |
4988 |
| Covid-19 and the cardiovascular system: a comprehensive review |
4989 |
| COVID-19: A Multidisciplinary Review |
4990 |
| Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches |
4991 |
| Computationally Optimized SARS-CoV-2MHC Class I and II Vaccine Formulations Predicted to Target Human Haplotype Distributions |
4992 |
| Child malnutrition and COVID-19: the time to act is now |
4993 |
| Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention |
4994 |
| Career Development Impacts of COVID-19: Practice and Policy Recommendations |
4995 |
| B-cell depletion with rituximab in the COVID-19 pandemic: where dowe stand? |
4996 |
| Asymptomatic COVID-19;We Don’t KnowWhat We Don’t Know |
4997 |
| Assessing the extent of SARS-CoV-2 circulation through serological studies |
4998 |
| Antivirals for COVID-19: a critical review |
4999 |
| Antibodies that potently inhibit or enhance SARS-CoV-2 spike protein-ACE2 interaction isolated from synthetic single-chain antibody libraries |
5000 |
| A special issue on SARS-CoV-2 |
5001 |
| A Review of Postmortem Findings in Patients With COVID-19 |
5002 |
| A negative covariation between toxoplasmosis and CoVID‑19 with alternative interpretations |
5003 |
| Worldwide SARS-COV-2 haplotype distribution |
5004 |
| World Health Organization (WHO) COVID-19 Database: Who needs it? |
5005 |
| Use of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic |
5006 |
| Tumor markers as an entry for SARS-CoV-2 infection? |
5007 |
| The relative infectiousness of asymptomatic SARS-CoV-2 infected persons compared with symptomatic individuals: A rapid scoping review. |
5008 |
| The level of effectiveness use of Quinoline Drugs in COVID-19 |
5009 |
| The influence of ABO blood groups on COVID-19 susceptibility and severity: a molecular hypothesis based on carbohydrate-carbohydrate interactions |
5010 |
| The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current immunotherapies for COVID-19 |
5011 |
| The ethics of COVID-19 treatment studies: too many are open, too few are double-masked |
5012 |
| The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review (version 6) |
5013 |
| Test for Covid-19 seasonality and the risk of second waves |
5014 |
| SARS-CoV-2-related atypical thyroiditis |
5015 |
| SARS-CoV-2 and the Role of Orofecal Transmission: Evidence Brief |
5016 |
| SARS-CoV-2 and Covid-19 Immunopathogenesis |
5017 |
| COVID 19 - Clinical Picture in the Elderly Population: A Qualitative Systematic Review |
5018 |
| Coronaviruses – a general introduction Who first described them; why they are called coronaviruses; what they are; how they invade cells; how we detect them |
5019 |
| Comparison of sixteen serological SARS-CoV-2 immunoassays in sixteen clinical laboratories |
5020 |
| Clinical features and risk factors for ICU admission in COVID-19 patients with cardiovascular diseases |
5021 |
| Bioactive Lipids as Mediators of the Beneficial Action(s) of Mesenchymal Stem Cells in COVID-19 |
5022 |
| Age-induced NLRP3 Inflammasome Over-activation Increases Lethality of SARS-CoV-2 Pneumonia in elderly Patients |
5023 |
| Vitamin D for COVID-19: a case to answer? |
5024 |
| Using serological data to understand unobserved SARS-CoV-2 risk in health-care settings |
5025 |
| Use of facemasks during the COVID-19 pandemic |
5026 |
| The Cummings effect: politics, trust, and behaviours during the COVID-19 pandemic |
5027 |
| Surveillance for COVID-19-associated pulmonary aspergillosis |
5028 |
| Stability of SARS-CoV-2 in different environmental conditions |
5029 |
| Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm |
5030 |
| Severe COVID-19 is marked by a dysregulated myeloid cell compartment |
5031 |
| SeroTracker: a global SARS-CoV-2 seroprevalence dashboard |
5032 |
| Seroprevalence of SARSCoV-2 in Hong Kong returnees |
5033 |
| Seroprevalence and presentation of SARS-CoV-2 in pregnancy |
5034 |
| SARS-CoV-2 viral load predicts COVID-19 mortality |
5035 |
| SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness |
5036 |
| Safety and COVID-19 symptoms in individuals recently vaccinated with BCG: a retrospective cohort study |
5037 |
| A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 |
5038 |
| Metformin, neutrophils and COVID-19 infection |
5039 |
| Metformin in COVID-19: A possible role beyond diabetes |
5040 |
| Neonates in the COVID-19 pandemic |
5041 |
| Nanotechnology versus coronavirus |
5042 |
| Morphogenesis and cytopathic effect of SARSCoV-2 infection in human airway epithelial cells |
5043 |
| Modelling the impact of COVID-19 on HIV |
5044 |
| Impact of COVID-19 on maternal and child health |
5045 |
| Impact of COVID-19 on maternal and child health |
5046 |
| Impact of COVID-19 on maternal and child health |
5047 |
| Impact of COVID-19 on maternal and child health |
5048 |
| Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection |
5049 |
| Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence |
5050 |
| Genetic variability in the expression of the SARS-CoV-2 host cell entry factors across populations |
5051 |
| Focus shifts to antibody cocktails for COVID-19 cytokine storm |
5052 |
| Fast-and-ft vaccines Results from the early trials of vaccine candidates against SARS-CoV-2 signal the ftness of vaccine technologies soon to be tested at scale. |
5053 |
| Elimination of COVID-19: what would it look like and is it possible? |
5054 |
| Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19 |
5055 |
| Dexamethasone nanomedicines for COVID- 19 Nano-formulating dexamethasone, and administering it via intravenous injection or inhalation, may help to improve anti-COVID-19 treatment efcacy by targeting the potent corticosteroid drug to hyper-activated immun |
5056 |
| Cross-reactivity towards SARS-CoV-2: the potential role of low-pathogenic human coronaviruses |
5057 |
| COVID-19—a very visible pandemic |
5058 |
| COVID-19—a very visible pandemic |
5059 |
| COVID-19—a very visible pandemic |
5060 |
| COVID-19—a very visible pandemic |
5061 |
| COVID-19—a very visible pandemic |
5062 |
| COVID-19—a very visible pandemic |
5063 |
| COVID-19—a very visible pandemic |
5064 |
| COVID-19 interstitial pneumonia: monitoring the clinical course in survivors |
5065 |
| CoViD vaccine results pour in |
5066 |
| COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19 |
5067 |
| Could telemedicine solve the cancer backlog? |
5068 |
| Coronavirus: Iran cover-up of deaths revealed by data leak |
5069 |
| Arboviruses and COVID-19: the need for a holistic view |
5070 |
| Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors |
5071 |
| Anosmia and hyposmia in health-care workers with undiagnosed SARS-CoV-2 infection |
5072 |
| Acute SARS-CoV-2 infection impairs dendritic cell and T cell responses |
5073 |
| A novel Monte carlo simulation procedure for modelling COVID 19 spread over time |
5074 |
| Drug treatments for covid-19: living systematic review and network meta-analysis |
5075 |
| What to do when the choice is no choice at all? A critical view on nutritional recommendations for CoVID-19 quarantine |
5076 |
| What is the Preferred Screening Tool for COVID-19 in Asymptomatic Patients Undergoing a Surgical or Diagnostic Procedure? |
5077 |
| Vitamin D for COVID-19: a case to answer? |
5078 |
| Vitamin D defciency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID 19 |
5079 |
| Vitamin D and Wellbeing beyond Infections: COVID-19 and Future Pandemics |
5080 |
| Virion structure and mechanism of propagation of coronaviruses including SARS-CoV 2 (COVID -19 ) and some meaningful points for drug or vaccine development |
5081 |
| Using serological data to understand unobserved SARS-CoV-2 risk in health-care settings |
5082 |
| Use of facemasks during the COVID-19 pandemic |
5083 |
Upper gastrointestinal bleeding in COVID-19 inpatients: incidence
and management in a multicenter experience from Northern Italy. |
5084 |
| Unravelling host-pathogen interactions: ceRNA network in SARSCoV-2 infection (COVID-19) |
5085 |
| Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2 |
5086 |
| To comfort always: Are we ignoring this duty in Covid protocols? |
5087 |
| Tissue-resident memory CD8 T-cell responses elicited by a single injection of a multi-target COVID-19 vaccine |
5088 |
| time, space and social interactions: exit mechanisms for the Covid 19 epidemics |
5089 |
| The Use of Mouthwashes against COVID-19 in Dentistry |
5090 |
| The role of the allergist/immunologist in the COVID-19 pandemic: A Janus-faced presentation |
5091 |
| The Review of COVID-19 Pandemic Disease |
5092 |
| The Interrelation of Neurological and Psychological Symptoms of COVID-19: Risks and Remedies |
5093 |
| The Good (But Not Great) News About T-Cells and Herd Immunity |
5094 |
| The dynamics of COVID-19 with quarantined and isolation |
5095 |
| The Cummings effect: politics, trust, and behaviours during the COVID-19 pandemic |
5096 |
| Ten key points about COVID-19 in children: the shadows on the wall |
5097 |
| Ten expert views on the COVID‑19 pandemic |
5098 |
| Tempering Macrophage plasticity for controlling SARS-CoV-2 infection for managing COVID-19 disease |
5099 |
| Systems-level immunomonitoring from acute to recovery phase of severe COVID-19 |
5100 |
| Surveillance for COVID-19-associated pulmonary aspergillosis |
5101 |
| Surface Chemistry Can Unlock Drivers of Surface Stability of SARS-CoV-2 in Variety of Environmental Conditions |
5102 |
| Stability of SARS-CoV-2 in different environmental conditions |
5103 |
| SRSF protein kinases 1 and 2 are essential host factors for human coronaviruses including SARS-CoV-2 |
5104 |
| Speci¦c Dynamic Variations in the Peripheral Blood Lymphocyte Subsets in COVID-19 and Severe In§uenza a Patients: A Retrospective Observational Study |
5105 |
Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and
tocilizumab-responding cytokine storm |
5106 |
| Simplest Way to Establish COVID-19 Quarantine Observation Wards Within 24 Hours |
5107 |
| Sex differential in COVID-19 mortality varies markedly by age |
5108 |
| Severe neurological complications in critically ill COVID‑19 patients |
5109 |
| Severe COVID-19 is marked by a dysregulated myeloid cell compartment |
5110 |
| SeroTracker: a global SARS-CoV-2 seroprevalence dashboard |
5111 |
| Seroprevalence of SARSCoV-2 in Hong Kong returnees |
5112 |
| Receptor utilization of angiotensin converting enzyme 2 (ACE2) indicates a narrower host range of SARS-CoV-2 than that of SARS-CoV |
5113 |
| Seroprevalence and presentation of SARS-CoV-2 in pregnancy |
5114 |
| Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans |
5115 |
| SARS-CoV-2 viral load predicts COVID-19 mortality |
5116 |
| SARS-CoV-2 PCR testing of skin for COVID-19 diagnostics: a case report |
5117 |
| SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness |
5118 |
| SARS-CoV, MERS-CoV and SARS-CoV-2: A DIAGNOSTIC CHALLENGE |
5119 |
| Safety of intermediate dose of low molecular weight heparin in COVID 19 patients |
5120 |
| Safety and COVID-19 symptoms in individuals recently vaccinated with BCG: a retrospective cohort study |
5121 |
| Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19 |
5122 |
| Regulatory CD4+ and CD8+ T cells correlated oppositely with CD4+/CD8+ T cell ratios in patients acutely infected with SARS-CoV-2 |
5123 |
| Reduction in the rate and improvement in the prognosis of COVID-19 in haematological patients over time |
5124 |
| The conundrum of interleukin-6 blockade in COVID-19 |
5125 |
| The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections |
5126 |
| Rational Design of SARS-CoV-2 Spike Glycoproteins To Increase Immunogenicity By T Cell Epitope Engineering |
5127 |
A Randomized Trial of Hydroxychloroquine as Postexposure
Prophylaxis for Covid-19 |
5128 |
| Pulmonary arterial thrombosis as an important complication of COVID-19 pulmonary disease: letter to the editor |
5129 |
| Protocol for a Rapid Scoping Review of Evidence of Outdoor Transmission of COVID-19 |
5130 |
| Prevention and Management of COVID-19 in Hemodialysis Centers |
5131 |
| Prediction and Analysis of SARS-CoV-2-Targeting microRNA in Human Lung Epithelium |
5132 |
| Potentially modifiable factors to reduce severity of COVID-19 in type 2 diabetes |
5133 |
Potential therapeutic application of mesenchymal stem cell-derived exosomes
in SARS-CoV-2 pneumonia
|
5134 |
| Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study |
5135 |
| Metformin, neutrophils and COVID-19 infection |
5136 |
| Metformin in COVID-19: A possible role beyond diabetes |
5137 |
| Patient-reported outcomes: central to the management of COVID-19 |
5138 |
| Online Search Trends Influencing Anti-Coagulation in COVID-19: A Retrospective Review |
5139 |
| Obesity and Smoking as Risk Factors for Invasive Mechanical Ventilation in COVID-19 Respiratory Failure: a Retrospective, Observational Cohort Study |
5140 |
| Obesity and COVID-19: Blame isn’t a strategy |
5141 |
| DRAFT landscape of COVID-19 candidate vaccines – 13 August 2020 |
5142 |
| No, All This COVID-19 Hand Washing Isn't Going to 'Weaken' Your Immune System |
5143 |
| Neonates in the COVID-19 pandemic |
5144 |
| Nanotechnology versus coronavirus |
5145 |
| Morphogenesis and cytopathic effect of SARSCoV-2 infection in human airway epithelial cells |
5146 |
| Modelling the impact of COVID-19 on HIV |
5147 |
| Modeling the Onset of Symptoms of COVID-19 |
5148 |
| Model-based Prediction of Critical Illness in Hospitalized Patients with COVID-19 |
5149 |
| Immunomodulatory Drugs in the Management of SARS-CoV-2 |
5150 |
Mismatch between circulating cytokines and spontaneous cytokine production by leukocytes in hyperinflammatory
COVID-19
|
5151 |
| Mini Review: Recent progress in RT-LAMP enabled COVID-19 detection |
5152 |
| Mental Health and the Aged in the Era of COVID-19 |
5153 |
| Mass screening of asymptomatic persons for SARS-CoV-2 using saliva |
5154 |
Management of Patients With Hematologic alignancies During the COVID-19 Pandemic: Practical
Considerations and Lessons to Be Learned
|
5155 |
| Low-cost measurement of facemask efficacy for filtering expelled droplets during speech |
5156 |
| Italian males recovering from mild COVID-19 show no evidence of SARS-CoV-2 in semen despite prolonged nasopharyngeal swab positivity |
5157 |
Indirect implications of COVID-19 prevention strategies on noncommunicable diseases An Opinion Paper of the European Society of Hypertension
Working Group on Hypertension and Cardiovascular Risk
Assessment in Subjects Living in or Emigrating from Low
Resource Settings
|
5158 |
| Inclusion of pregnant women in COVID-19 vaccine development |
5159 |
| Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection |
5160 |
| IL‐18 and infections: Is there a role for targeted therapies? |
5161 |
| Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study |
5162 |
| Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence |
5163 |
| High power laser use in the COVID-19 pandemic era in dentistry: tips for the readers |
5164 |
| High neutrophil to lymphocyte ratio as a prognostic marker in COVID-19 patients |
5165 |
| The EVALI outbreak and vaping in the COVID-19 era |
5166 |
| Haemodynamic Monitoring and Management in COVID-19 Intensive Care Patients: An International Survey |
5167 |
| Genetic variability in the expression of the SARS-CoV-2 host cell entry factors across populations |
5168 |
| Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion |
5169 |
| Forward planning for disaster-related mass gatherings amid COVID-19 |
5170 |
| Focus shifts to antibody cocktails for COVID-19 cytokine storm |
5171 |
| Familial Clustering of COVID-19 Skin Manifestations |
5172 |
| Factors Associated with Disease Severity and Mortality among Patients with Coronavirus Disease 2019: A Systematic Review and Meta-Analysis |
5173 |
| Face mask use in the general population and optimal resource allocation during the COVID-19 pandemic |
5174 |
| Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study |
5175 |
| Examining face-mask usage as an effective strategy to control COVID-19 spread |
5176 |
| Ex vivo detection of SARS-CoV-2-specific CD8+ T cells: rapid induction, prolonged contraction, and formation of functional memory |
5177 |
| Evolving ethics of COVID-19 challenge trials |
5178 |
| Endothelial Injury and Thrombotic Microangiopathy in COVID-19: Treatment with the Lectin-Pathway Inhibitor Narsoplimab |
5179 |
| Elimination of COVID-19: what would it look like and is it possible? |
5180 |
| Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19 |
5181 |
| Efficacy of Corticosteroids in COVID-19 Patients: A Systematic Review and Meta-Analysis |
5182 |
| Effect of Convalescent Plasma on Mortality among Hospitalized Patients with COVID-19: Initial Three- Month Experience |
5183 |
| ECMO for severe ARDS associated with COVID-19: now we know we can, but should we? |
5184 |
| Early onset SARS-CoV-2 pneumonia in a preterm neonate – Probably acquired through vertical transmission |
5185 |
| Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020 |
5186 |
| Digestive symptoms of COVID-19 and expression of ACE2 in digestive tract organs |
5187 |
| Differential methylation as a mediator of COVID-19 susceptibility |
5188 |
| Dexamethasone nanomedicines for COVID-19 |
5189 |
| Dental procedure aerosols and COVID-19 |
5190 |
Cytokine storm release syndrome and the prospects for immunotherapy with COVID-19, part 3: The role of GM-CSF
Posted August 10, 2020
|
5191 |
| Cytokine storm and the prospects for immunotherapy with COVID-19 |
5192 |
Cytokine release syndrome and the prospects
for immunotherapy with COVID-19. Part 2: The role of interleukin 1 Posted June 24, 2020 |
5193 |
| Cross-reactivity towards SARS-CoV-2: the potential role of low-pathogenic human coronaviruses |
5194 |
| Cross-continental comparison of safety and protection measures amongst urologists during COVID-19 |
5195 |
| COVID-19 Viral Load in the Severity of and Recovery from Olfactory and Gustatory Dysfunction |
5196 |
COVID-19 vaccination intention in the UK: Results from the ‘COVID-19 Vaccination Acceptability Study’ (CoVAccS), a nationally representative
cross-sectional survey
|
5197 |
| COVID-19 Usurps Host Regulatory Networks |
5198 |
| COVID-19’s impact on Australia’s health research workforce |
5199 |
| COVID-19 Therapy: Could a Chlorophyll Derivative Promote Cellular Accumulation of Zn2+ Ions to Inhibit SARS-CoV-2 RNA Synthesis? |
5200 |
| COVID-19 pandemic more than a century after the Spanish flu |
5201 |
| COVID-19 is an opportunity for reform in dentistry |
5202 |
| COVID-19 interstitial pneumonia: monitoring the clinical course in survivors |
5203 |
| COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matter |
5204 |
| Covid-19 and promising solutions to combat symptoms of stress, anxiety and depression |
5205 |
| COVID-19 and haematological malignancy: navigating a narrow strait |
5206 |
| Role of ACE2 Receptor and the landscape o |
